Fatigue in patients with hereditary neuropathy with liability to pressure palsies.

Nora E FritzYongsheng ChenLauren WatersSadaf SabaMelody HackettFlicia C MadaJun Li

Published in: Annals of clinical and translational neurology (2020)

Fatigue is common and severe among patients with HNPP whose disabilities are minimal by conventional outcome measures. Therapeutic interventions targeting fatigue have the potential to improve quality of life and may serve as a robust outcome measure to show longitudinal changes for patients with HNPP.

Keyphrases

sleep quality
physical activity
depressive symptoms
human health
risk assessment
drug induced